0001380106-24-000132.txt : 20240524 0001380106-24-000132.hdr.sgml : 20240524 20240524172444 ACCESSION NUMBER: 0001380106-24-000132 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240523 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240524 DATE AS OF CHANGE: 20240524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPID MICRO BIOSYSTEMS, INC. CENTRAL INDEX KEY: 0001380106 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40592 FILM NUMBER: 24985587 BUSINESS ADDRESS: STREET 1: 1001 PAWTUCKET BLVD. CITY: LOWELL STATE: MA ZIP: 01854 BUSINESS PHONE: 978-349-3200 MAIL ADDRESS: STREET 1: 1001 PAWTUCKET BLVD. CITY: LOWELL STATE: MA ZIP: 01854 FORMER COMPANY: FORMER CONFORMED NAME: RAPID MICRO BIOSYSTEMS INC DATE OF NAME CHANGE: 20061103 8-K 1 rpid-20240523.htm 8-K rpid-20240523
0001380106false12/3100013801062024-05-232024-05-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 23, 2024
RAPID MICRO BIOSYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Delaware001-4059220-8121647
(State or other jurisdiction
of incorporation or organization)		(Commission
File Number)		(I.R.S. Employer
Identification No.)
 1001 Pawtucket Boulevard West, Suite 280, Lowell, MA
01854
(Address of principal executive offices)
(Zip Code)
978-349-3200
(Registrant’s telephone number, including area code)

N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbols		Name of each exchange on which
registered
Class A Common Stock, $0.01 par value per shareRPIDThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company þ
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o




Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 23, 2024, Rapid Micro Biosystems, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Restated Certificate of Incorporation, which became effective on such date. A copy of the Certificate of Amendment is included as Exhibit 3.1 and is incorporated herein by reference.
Item 5.07    Submission of Matters to a Vote of Security Holders.

The Company held its annual meeting of stockholders on May 23, 2024 (the “Annual Meeting”), at which a quorum was present. There were three items of business acted upon by the stockholders. There were 37,483,559 shares of the Company’s Class A common stock eligible to vote, and 35,030,255 shares were present in person or by proxy at the Annual Meeting. The following is a summary of the matters voted on at the Annual Meeting:

1.    The Company’s stockholders elected Kirk D. Malloy, Ph.D., Melinda Litherland and Robert Spignesi as Class III Directors to serve until the 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.

The results of the stockholders’ vote with respect to the election of such Class III Directors were as follows:
Votes For
Votes
Withheld
Broker
Non-Votes
Kirk D. Malloy, Ph.D.26,146,777634,8088,248,670
Melinda Litherland25,722,2321,059,3538,248,670
Robert Spignesi25,714,5631,067,0228,248,670

2.    The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The results of the stockholders’ vote with respect to such ratification were as follows:
Votes For
Votes
Against
Votes
Abstaining
Broker
Non-Votes
34,230,103790,9039,2490

3.    The Company’s stockholders approved a Certificate of Amendment to the Company's Restated Certificate of Incorporation to reflect new Delaware law provisions allowing for officer exculpation. The results of the stockholders’ vote with respect to such approval were as follows:
Votes For
Votes
Against
Votes
Abstaining
Broker
Non-Votes
26,096,227673,92011,4388,248,670

No other matters were submitted to or voted on by the Company’s stockholders at the Annual Meeting.
Item 9.01    Financial Statements and Exhibits.
(d)Exhibits.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
RAPID MICRO BIOSYSTEMS, INC.
Date: May 24, 2024By:/s/ Sean Wirtjes
Sean Wirtjes
Chief Financial Officer

 EX-3.1 2 ex31_rpidxamendmenttochart.htm EX-3.1 Document


Certificate of Amendment to the Restated Certificate of Incorporation of Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. (the “Corporation”), a corporation duly organized and existing under the laws of the State of Delaware pursuant to Section 242 of the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows:

1.The Restated Certificate of Incorporation of the Corporation is hereby amended by adding a new Article TWELFTH, which shall read in its entirety as follows:

“TWELFTH: To the fullest extent permitted by the General Corporation Law of the State of Delaware, an Officer (as defined below) of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of his or her fiduciary duty as an officer of the Corporation, except for liability (a) for any breach of the Officer’s duty of loyalty to the Corporation or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) for any transaction from which the Officer derived an improper personal benefit, or (d) arising from any claim brought by or in the right of the Corporation. If the General Corporation Law of the State of Delaware is amended after the effective date of this Restated Certificate of Incorporation to authorize corporate action further eliminating or limiting the personal liability of Officers, then the liability of an Officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law of the State of Delaware, as so amended. For purposes of this Article TWELFTH, “Officer” shall mean an individual who has been duly appointed as an officer of the Corporation and who, at the time of an act or omission as to which liability is asserted, is deemed to have consented to service by the delivery of process to the registered agent of the Corporation as contemplated by Section 3114(b) of Title 10 of the General Corporation Law of the State of Delaware.”

Any amendment, repeal or modification of this Article TWELFTH by either of (i) the stockholders of the Corporation or (ii) an amendment to the General Corporation Law of the State of Delaware, shall not adversely affect any right or protection existing at the time of such amendment, repeal or modification with respect to any acts or omissions occurring before such amendment, repeal or modification of a person serving as an Officer at the time of such amendment, repeal or modification.”

2.The Board of Directors of the Corporation has adopted a resolution approving and declaring advisable the foregoing amendment set forth in this Certificate of Amendment in accordance with the provisions of Section 242 of the DGCL.

3.The stockholders of the Corporation, at a meeting duly called and held pursuant to Section 222 of the DGCL, duly adopted the amendments set forth in this Certificate of Amendment in accordance with the provisions of Section 242 of the DGCL.

4.The foregoing amendments were duly adopted in accordance with Section 242 of the DGCL.

IN WITNESS WHEREOF, the undersigned, as a duly authorized officer of the Corporation, has executed this Certificate of Amendment on May 23, 2024.

Rapid Micro Biosystems, Inc.
/s/ Robert Spignesi
Name:    Robert Spignesi
Title:    President and Chief Executive Officer


 EX-101.SCH 3 rpid-20240523.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 rpid-20240523_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Soliciting Material Soliciting Material Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Tax Identification Number Entity Tax Identification Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, City or Town Entity Address, City or Town Local Phone Number Local Phone Number Written Communications Written Communications Cover [Abstract] Cover [Abstract] Document Type Document Type Entity Ex Transition Period Entity Ex Transition Period Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 rpid-20240523_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover Page
May 23, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 23, 2024
Entity Registrant Name RAPID MICRO BIOSYSTEMS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40592
Entity Tax Identification Number 20-8121647
Entity Address, Address Line One 1001 Pawtucket Boulevard West
Entity Address, Address Line Two Suite 280
Entity Address, City or Town Lowell,
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01854
City Area Code 978
Local Phone Number 349-3200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, $0.01 par value per share
Trading Symbol RPID
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001380106
Amendment Flag false
Current Fiscal Year End Date --12-31
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 25 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://rapidmicrobio.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports rpid-20240523.htm rpid-20240523.xsd rpid-20240523_lab.xml rpid-20240523_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "rpid-20240523.htm": { "nsprefix": "rpid", "nsuri": "http://rapidmicrobio.com/20240523", "dts": { "inline": { "local": [ "rpid-20240523.htm" ] }, "schema": { "local": [ "rpid-20240523.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "rpid-20240523_lab.xml" ] }, "presentationLink": { "local": [ "rpid-20240523_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2022": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 25 }, "report": { "R1": { "role": "http://rapidmicrobio.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "rpid-20240523.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "rpid-20240523.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine2", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityExTransitionPeriod", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://rapidmicrobio.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001380106-24-000132-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001380106-24-000132-xbrl.zip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rpid-20240523_htm.xml IDEA: XBRL DOCUMENT 0001380106 2024-05-23 2024-05-23 0001380106 false --12-31 8-K 2024-05-23 RAPID MICRO BIOSYSTEMS, INC. DE 001-40592 20-8121647 1001 Pawtucket Boulevard West Suite 280 Lowell, MA 01854 978 349-3200 false false false false Class A Common Stock, $0.01 par value per share RPID NASDAQ true false